Charles River Laboratories (CRL) stock news · rev $4.02B
Charles River Laboratories (CRL) is a diagnostics & research company listed on US.
This CRL news page leads with what Charles River Laboratories filed — not a scraped headline mill.
No cached 8-K sentence for CRL yet. We will not pad this page with generic market recap.
Latest reported CRL revenue for 2025-12-27 was $4.02B. Net income was -$144.3M. Revenue was down 0.9% from 2024-12-28 to 2025-12-27. CRL currently screens at market cap $7.78B.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the CRL stock page; for the tape open the quote page.
CRL stock news FAQ
What are CRL's latest revenue and net income?
Latest cached Charles River Laboratories (CRL) revenue for Dec 27, 2025 was $4.02B. Net income was -$144.3M. Statements: https://lician.com/financials/crl
How did CRL revenue change from the prior cached period?
Cached Charles River Laboratories (CRL) revenue was down 0.9% from $4.05B (Dec 28, 2024) to $4.02B (Dec 27, 2025). Statements: https://lician.com/financials/crl
What is CRL's market cap?
Charles River Laboratories (CRL) market cap is $7.78B on the latest cached fundamentals snapshot.
What kind of company is CRL?
Charles River Laboratories (CRL) is a diagnostics & research company listed on US.
Where is CRL stock news listed?
Cached stock news for Charles River Laboratories (CRL) is listed at https://lician.com/news/crl. Filings: https://lician.com/sec/crl
Not investment advice.